And trust me, it is a tender offer. After purchasing our initial tranche of 1,960 China Biodiesel shares back in July 2009 for 6.6 pence a share and topping up a short week later at 10.06 pence (yep that’s a 50% rise in that short week), we were averaged into CBI.L at 9.29 pence a share. And whilst the share price did go on to test 20 pence in August 2009, since then there’s been a lot...

A few days back I wrote about Renesola testing new recent highs in the lead-up to results and how the situation in Greece threw a bit of spanner into the works. Well results have come and gone, and not bad results at that, but having a bit of a conservative edge about me of late, I took a little profit, realising 400 shares at £2.41 a share for a return before costs of £964. We were averaged int...

It’s with a heavy heart that today I write about my sale of West China Cement. Our brief love affair – this time around, for we have loved before – began in July 2009 when I picked up 153 of these little grey beauties at £1.70. Watching our love take flight, two short weeks later I added another 221 shares at an already soaring £2.57. My 374 shares were averaged in at £2.21, f...

Eros International wasn’t the only holding to get a trim following our decision to add OPG Power Ventures to the Investor Trader Radar. For those of you that have followed Investor Trader over the journey you’ll know that we often buy and sell a little Renesola on the dips and peaks. And although we believe Rensola’s current surge toward £2 still has a ways to travel, we sold 29...

After adding OPG Power Ventures to the Investor Trader Radar we decided it was time to raise a little capital to facilitate a purchase. We settled on liduidating the remaining tranche of our EROS International holdings for no better reason than we needed the dinero. We were averaged into Eros International (EROS.L) at 105 pence and sold out at 165 pence turning a £180 profit on the final 300 shar...

Today we sold our holding of 82 shares in Synergy Health PLC (SYR.L) for £5.8730 a share, netting us a total return of £481.59 before costs. We got on board with Synergy Health back in mid-July of this year at £5.0800 a share. In 3 and a half months we’ve made 79.3 pence per share – a 13.5% gain. Our reasons for selling? A simple case of opportunity cost. Again, we see Synergy Healt...

The last couple of weeks has seen a little turnaround in the fortunes of our – predominantly – small capped portfolio. The recent rise and rise of the FTSE seems to indicate that there’s still faith in the market in general so maybe it’s a case of people taking from AIM to invest in the main board. Whatever the case, we’ve decided to pocket a little profit from our Cl...

Yesterday we offloaded our holding of Low Carbon Accelerator (LCA.L) selling 1,834 shares for 31 pence each for a total return of £568.54 (before costs). Low Carbon Accelerator were one of the original three holdings we kicked off Investor Trader with back in April 2009, but sentiment be damned! We returned a small profit (very small after broker’s costs) after buying in at 29.5 pence a sha...

Today we sold our holding of 100 shares of Lyxor ETF India (the fund that tracks the S&P CNX NIFTY Index – the nifty fifty – the leading index for large companies on the National Stock Exchange of India) for £5.88 a share for a total return £588. Our original purchase of 100 shares was made on the 17th June 2009 for £5.6999 a share for a total outlay of £569.99. Our return befo...

So we offloaded our parcel of Climate Exchange today. Since we began our Investor Trader experiment Climate Exchange has risen from £7.00 to £9.15, a 30.7% rise in 3 and a half months. Not too shabby in anyone’s books. A lot of that in the past 4 weeks based on a little healthy takeover speculation. Now nothing has changed since, but the upward momentum seems to have peaked and I’d e...